TTP plc selected for technology advisory partnership with Cancer Research UK

TTP plc (TTP), a leading independent technology and product development company, today announced that it has entered into a technology advisory partnership with Cancer Research UK.

Cancer Research UK

Image Credit: chrisdorney/Shutterstock.com

TTP has been selected by Cancer Research UK to apply its technology design and development expertise and insight in the healthcare sector, to assess discoveries made by the charity’s academic researchers.

Under the terms of the agreement, TTP will review and evaluate the clinical and commercial applications of emerging technologies, to support Cancer Research UK’s pioneering work into the prevention, diagnosis, and treatment of cancer.

TTP was chosen to work with Cancer Research UK due to its breadth of development skills and experience in progressing a product idea to manufacture, to advance the charity’s research in areas including medical devices, diagnostics, sensors and artificial intelligence (AI).

Dr. Michelle Griffin, Clinical Innovator, TTP plc, said: “Being chosen to work with such a prestigious organization demonstrates our credibility and trusted experience within healthcare technology development. Our expertise across the sector compliments Cancer Research UK’s breadth of research techniques, and we look forward to applying this deep knowledge to find new and exciting methods to beat cancer, sooner.”

We have access to a fantastic portfolio of emerging tech through the Cancer Research UK academic community and are eager to see this reach the healthcare setting as soon as possible. Our partnership with TTP plc is a great opportunity for Cancer Research UK as it will enable us to deliver our most promising technologies to the clinic, shaping the future of how people with cancer are diagnosed, treated, and monitored.”

Tony Hickson, Chief Business Officer, Cancer Research UK

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    TTP plc. (2020, June 29). TTP plc selected for technology advisory partnership with Cancer Research UK. News-Medical. Retrieved on June 18, 2024 from https://www.news-medical.net/news/20200629/TTP-plc-selected-for-technology-advisory-partnership-with-Cancer-Research-UK.aspx.

  • MLA

    TTP plc. "TTP plc selected for technology advisory partnership with Cancer Research UK". News-Medical. 18 June 2024. <https://www.news-medical.net/news/20200629/TTP-plc-selected-for-technology-advisory-partnership-with-Cancer-Research-UK.aspx>.

  • Chicago

    TTP plc. "TTP plc selected for technology advisory partnership with Cancer Research UK". News-Medical. https://www.news-medical.net/news/20200629/TTP-plc-selected-for-technology-advisory-partnership-with-Cancer-Research-UK.aspx. (accessed June 18, 2024).

  • Harvard

    TTP plc. 2020. TTP plc selected for technology advisory partnership with Cancer Research UK. News-Medical, viewed 18 June 2024, https://www.news-medical.net/news/20200629/TTP-plc-selected-for-technology-advisory-partnership-with-Cancer-Research-UK.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
TTP partners with Quotient to transform transfusion diagnostics and beyond